Cargando…
Randomized study on the effectiveness of nomegestrol acetate plus 17β-estradiol oral contraceptive versus dienogest oral pill in women with suspected endometriosis‑associated chronic pelvic pain
BACKGROUND: To evaluate the effects of a combined oral contraceptive containing 1.5 mg 17b-estradiol (E2) and 2.5 mg nomegestrol acetate (NOMAC) or 2 mg/daily dienogest (DNG) oral progestin on endometriosis-associated chronic pelvic pain (CPP) and on the quality of life (QoL) and sexual function, by...
Autores principales: | Caruso, Salvatore, Cianci, Antonio, Iraci Sareri, Marco, Panella, Marco, Caruso, Giuseppe, Cianci, Stefano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092804/ https://www.ncbi.nlm.nih.gov/pubmed/35538479 http://dx.doi.org/10.1186/s12905-022-01737-7 |
Ejemplares similares
-
Does Nomegestrol Acetate Plus 17β-Estradiol Oral Contraceptive Improve Endometriosis-Associated Chronic Pelvic Pain in Women?
por: Caruso, Salvatore, et al.
Publicado: (2020) -
Nomegestrol acetate-17b-estradiol for oral contraception
por: Burke, Anne
Publicado: (2013) -
Effects of long-term treatment with Dienogest on the quality of life and sexual function of women affected by endometriosis-associated pelvic pain
por: Caruso, Salvatore, et al.
Publicado: (2019) -
Endometrial safety of an oral contraceptive containing estradiol valerate and dienogest
por: Bitzer, Johannes, et al.
Publicado: (2011) -
Estradiol valerate and dienogest: a new approach to oral contraception
por: Kiley, Jessica W, et al.
Publicado: (2011)